New York · 2025 Regular Session · Bill

A 2650: Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

In committee Last action January 7, 2026: REFERRED TO INSURANCE

Plain-language summary

A 2650 is a bill introduced in the New York House on January 21, 2025. According to its official title, it concerns: Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology. Primary sponsor: Nader Sayegh (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO INSURANCE.

Sponsors

Primary sponsor: Nader Sayegh (Democratic).